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Background: The 5-year survival rate for breast cancer among Korean women has increased steadily; however,
breast cancer remains the leading cause of cancer mortality among women. One-carbon metabolism, which
requires an adequate supply of methyl group donors and B vitamins, may affect the prognosis of breast cancer.
This aim of this study was to investigate the associations of dietary intake of vitamin B2, vitamin B6 and folate
before diagnosis on the prognosis of breast cancer.
Methods: We assessed the dietary intake using a food frequency questionnaire with 980 women who were newly
diagnosed and histopathologically confirmed to have primary breast cancer from hospitals in Korea, and 141
disease progression events occurred. Cox’s proportional hazard regression models were used to estimate the hazard
ratio (HR) and 95% confidence interval (95% CI) adjusting for age, education, recruitment sites, TNM stage,
hormone status, nuclear grade and total calorie.
Results: There was no significant association between any one-carbon metabolism related nutrients (vitamin B2, B6
and folate) and the progression of breast cancer overall. However, one-carbon metabolism related nutrients were
associated with disease progression in breast cancer patients stratified by subtypes. In ER + and/or PR + breast
cancers, no association was observed; however, in ER–/PR– breast cancers, a high intake of vitamin B2 and folate
statistically elevated the HR of breast cancer progression (HR = 2.28; 95% CI, 1.20-4.35, HR = 1.84; 95% CI, 1.02-3.32,
respectively) compared to a low intake. This positive association between the ER/PR status and progression of the
disease was profound when the nutrient intakes were categorized in a combined score (Pinteraction = 0.018).
In ER–/PR– breast cancers, high combined scores were associated with a significantly poor DFS compared to those
belonging to the low score group (HR = 3.84; 95% CI, 1.70-8.71).
Conclusions: In conclusion, our results suggest that one-carbon related nutrients have a role in the prognosis of
breast cancer depending on the ER/PR status.
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Breast cancer is the second most common malignancy
in Korea. The 5-year survival rate for breast cancer
among Korean women has increased from 78.0% during
1993–1995 to 89.5% during 2003–2007. Despite such
marked improvement, breast cancer remains the second
leading cause of cancer mortality among women in
Korea [1]. Analyzing prognostic factors associated with
breast cancer survival and recurrence is important for
early detection and chemotherapy.
Known prognostic indicators such as pathological cri-
teria including tumor size, lymph-node status and hor-
mone receptor status are pathologically used in clinical
practice [2]. Although numerous studies have shown
that disease-free survival after breast cancer treatment
may be partially predicted by pathological factors [3,4],
they are not yet predicted prognostic factors for each pa-
tient in clinical practice.
Epigenetic aberrations occur in tumor cells; especially,
CpG-island hypermethylation and global genomic hypo-
methylation are common features of breast cancer cells
[5]. A lack of methyl supply can induce DNA global
hypomethylation as well as incomplete conversion of
dUMP to dTMP leading to uracil misincorporation into
DNA [6]. One-carbon metabolism is a network of inter-
related biochemical reactions that include the transfer of
one-carbon groups [7], which have two major functions:
DNA methylation and DNA synthesis [8].
The principal element of one-carbon metabolism is fol-
ate, since the one-carbon transfer reactions involve inter-
conversion between several forms of this nutrient. Other
important nutrients in one-carbon metabolism include
vitamins B2, B6 and B12, which act as essential cofactors
for one or more enzymes that catalyze one-carbon trans-
fer reactions. Vitamin B2 is a cofactor for methylenete-
trahydrofolate reductase, the critical folate-dependent
enzyme. Vitamin B6 has a role in the conversion of tetra-
hydrofolate to 5, 10-methylenetetrahydrofolte, which is
required for the synthesis of thymidylate and a precursor
for purine synthesis [9,10].
Previous studies have suggested that a high status of
one-carbon metabolism factors has reduced the risk of
several cancers, including colorectal, pancreatic, esopha-
geal, renal cell, and breast cancer [11-15]. In studies
related to breast cancer risk, folate has been investigated
many times. Although a number of cohort and case–
control studies have suggested a protective effect for a
high folate status on breast cancer risk, these results are
far from conclusive. And other B vitamins did not
showed any associations with breast cancer risk [15]. For
studies on one-carbon metabolism related nutrients and
breast cancer survival, a few investigated the association
between folate intake and breast cancer survival with in-
consistent results. In a Swedish mammography study,high folate intake before breast cancer diagnosis improved
the prognosis of the breast cancer and overall survival
[16]. However, in the Long Island Breast Cancer Study
Projects and Nurses’ Health study, the association be-
tween vitamin B2, B6 and folate and breast cancer progno-
sis had null results [17,18].
One-carbon metabolism, which requires an adequate
supply of methyl group donors and B vitamins, may
modify the methylation profile of the genome, thus in-
fluencing breast cancer prognosis. The aim of this study
was to investigate the associations of dietary intake of
vitamin B2, vitamin B6 and folate before diagnosis on the
prognosis of breast cancer.
Materials and methods
Study population
A total of 1,586 newly diagnosed breast cancer cases
were recruited from Seoul National University Hospital
and Asan Medical Center in Korea from 2004 to 2007
[19]. Before any adjuvant chemotherapy and/or surgery,
baseline data were collected using questionnaires.
Patients with a prehistory of cancer, multiple cancers at
diagnosis, distant organ metastasis at diagnosis, in situ
breast cancer and unobtainable of dietary assessment
were excluded. Subjects with a total energy intake from
500 to 3,500 kcal/day were included for the final ana-
lysis. In the final analysis, a total of 980 invasive ductal
carcinoma cancer patients diagnosed with stage I - III
who underwent curative resection were included.
The study was approved by the Committee on Human
Research of Seoul National University Hospital (IRB No.
H-0503-144-004). All participants provided informed
consent before their participation in the study.
Data collection
The demographic characteristics of the participants were
obtained by trained interviewers using a structured
questionnaire. Information on demographic characteris-
tics including age, education, reproductive and men-
strual factors and lifestyle habits including smoking
status, and alcohol consumption were collected.
A retrospective chart review was used to collect clini-
copathological information including cancer stage,
tumor size, lymph-node status, distant organ metastasis,
estrogen receptor (ER) and progesterone receptor (PR)
status, nuclear grade, surgical treatment and medical ad-
juvant therapy. Death was ascertained from Statistics
Korea.
The food frequency questionnaire (FFQ) included 103
food items and detailed information on the FFQ has
been described in a previous study [20]. During the in-
person interviews, each participant was asked about
their dietary habits for one year before the date of diag-
nosis. The frequency of servings was classified into nine
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month, one to two times a week, three to four times a
week, five to six times a week, once a day, twice a day or
three times or more every day. For food items with differ-
ent seasonal availability, we requested that participants
choose one category for how long they have eaten a par-
ticular food item from among four categories: 3, 6, 9 or
12 months. The portion size of each food item was classi-
fied as follows: small, medium or large. To help in under-
standing portion sizes, we provided pictures on serving
sizes for food items on their corresponding pages. The re-
producibility and validity of the FFQ were analyzed for
124 subjects in a previous study [20]. The FFQ was
assessed twice at 1-year intervals for the reproducibility
analysis. The correlation coefficients of the nutrients were
0.54, 0.44 and 0.43 for vitamin B2 (unpublished data),
vitamin B6 and folate, respectively. FFQs were compared
with 12-day diet records (3 days during each of the four
seasons) for the validity analysis. The correlation coeffi-
cients of the nutrients were ranged from 0.15 to 0.31 for
vitamin B2 (unpublished data), vitamin B6 and folate [20].
Statistical analysis
Disease free survival (DFS) was defined as the time from
the date of surgery to the date of the first locoregional re-
currence, first distant metastasis, 2nd primary cancer or
death from any cause. Patients known to be alive with no
evidence of disease were censored at the last follow-up date.
Cox’s proportional hazard regression models were used
to estimate the hazard ratio (HR) and 95% confidence
interval (95% CI). Multivariate Model 1 included age,
TNM stage, hormone status and nuclear grade while
Model 2 included age, education, recruitment sites, TNM
stage, hormone status and nuclear grade. In addition, one-
carbon metabolism related nutrients were adjusted for
total calories in both Model 1 and Model 2. The adjusted
variables in Model 1 were known factors of breast cancer
prognosis and the variables added to Model 2 were known
factors related to the intake of nutrients. Other covariates
including tumor size and lymph node status were consid-
ered but not included in the final model, since the TNM
stage was adjustment variable in the final model.
We performed analyses with vitamin B2, vitamin B6 and
folate as continuous variables and as categorical variables
in quartiles. To further assess the combined effects of the
intake of one-carbon metabolism related nutrients includ-
ing vitamin B2, vitamin B6 and folate on breast cancer sur-
vival, each vitamin was coded as 0 or 1 by median, and
calculated using the sum of the numbers. The combined
score was categorized into three groups which were low
(score, 0), medium (score, 1–2) and high (score, 3).
Wald P values for trends were computed by treating
categorical variables as ordinal variables. P for inter-
action was analyzed by multiplying two variables.Additionally, stratified analyses were done according
to age (≤39, 40–49, 50–59, and ≥60), menopausal status,
BMI group (<25 kg/m2 and ≥25 kg/m2), alcohol con-
sumption (<1/month, 1+/month), TNM stage (I-II and
III), lymph-node status (negative and positive), hormone
status (ER+ and/or PR+ and ER–/PR–) and nuclear
grade (I-II and III).
All statistical analyses were done using SAS statistical
software version 9.2 (SAS Institute, Cary, NC).Results
The median follow-up time was 5.3 years (range, 0.2-
7.0 years). There were 141 DFS events including 77
deaths from any cause among all 980 patients. Table 1
summarizes the association between demographic and
clinicopathological factors and progression in breast can-
cer patients. In this study, breast cancer patients who
were estrogen receptor negative (ER–) and progesterone
receptor negative (PR–) were 39.2% and 44.2%, respect-
ively. Among demographic factors, patients with an edu-
cation higher than the college level were associated with
progression of breast cancer compared to the patients
with an education lower than middle school. Among
clinical factors, TNM stage, tumor size, lymph node sta-
tus and hormone status were significant prognostic fac-
tors for breast cancer (P < 0.05).
Table 2 presents the association between one-carbon
metabolism related nutrients intake and disease progres-
sion in breast cancer patients. The mean intakes ± SD of
vitamin B2, B6 and folate were 1.0 ± 0.4 mg, 1.5 ± 0.5 mg
and 213.8 ± 99.3 mg respectively. Patients with a high
(range, > median) intake of vitamin B2, B6, and folate
had an increased HR for the recurrence compared to the
patients with a low (range, < median) intake; however,
the association was not statistically significant. When
examining the association between the combined effects
of vitamin B2, B6 and folate intake on the progression of
breast cancer, the HR was 1.46 (95% CI, 0.87-2.43) for
the high combined score group (range, 3) compared to
the low combined score group (range, 0).
Table 3 presentes the association between the median
of one-carbon metabolism related nutrients intake and
disease progression in breast cancer patients stratified by
clinicopathological characteristics. No differential associ-
ation was found between the intake levels of vitamin B2,
B6, and folate and disease progression stratified by TNM
stage, lymph-node status, or nuclear grade. However, in
ER–/PR– breast cancers, a high intake of vitamin B2 and
folate statistically elevated the HR of breast cancer pro-
gression compared to a low intake (HR=2.28; 95% CI,
1.20-4.35, HR= 1.84; 95% CI, 1.02-3.32, respectively). Low
versus high (reference= low) intake of vitamin B6 showed
an increased HR for breast cancer progression; however,
Table 1 Hazard ratios for disease progression in breast cancer patients
All (N= 980) Events (N = 141) Model 1a Model 2b
Age (mean(SD)) 48 (9.8) 49 (11.7) 1.02 (1.00-1.04) 1.01 (0.99-1.03)
≤39 191 (19.5) 30 (21.3) 1.00 1.00
40-49 422 (43.0) 50 (35.5) 0.86 (0.54-1.36) 0.76 (0.48-1.22)
50-59 241 (24.6) 34 (24.1) 1.02 (0.62-1.70) 0.83 (0.48-1.42)
≥60 126 (12.9) 27 (19.1) 1.66 (0.97-2.82) 1.21 (0.67-2.18)
Menopausal status
Pre 610 (63.0) 74 (53.6) 1.00 1.00
Post 359 (37.0) 64 (46.4) 1.50 (0.93-2.42) 1.38 (0.85-2.25)
BMI, kg/m2 (mean(SD)) 23 (2.9) 23 (3.2) 0.98 (0.92-1.04) 0.97 (0.91-1.03)
<25 753 (77.6) 107 (77.0) 1.00 1.00
≥25 217 (22.4) 32 (23.0) 0.85 (0.56-1.28) 0.79 (0.52-1.20)
Education
Middle school 224 (22.9) 46 (32.6) 1.00 1.00
High school 402 (41.2) 56 (39.7) 0.68 (0.45-1.05) 0.69 (0.45-1.05)
College 351 (35.9) 39 (27.7) 0.58 (0.36-0.94) 0.58 (0.36-0.93)
Alcohol drinking
<1/month 559 (57.5) 85 (60.7) 1.00 1.00
1-3/month 354 (36.4) 46 (32.9) 0.83 (0.57-1.21) 0.83 (0.57-1.22)
1+/week 59 (6.1) 9 (6.4) 1.12 (0.56-2.25) 1.09 (0.54-2.19)
Recruited sites
SNU 511 (52.1) 73 (51.8) 1.00 1.00
AMC 469 (47.9) 68 (48.2) 0.92 (0.65-1.30) 0.89 (0.63-1.26)
TNM stage
I 400 (40.8) 25 (17.7) 1.00 1.00
II 416 (42.5) 72 (51.1) 2.78 (1.74-4.44) 2.71 (1.69-4.35)
III 164 (16.7) 44 (31.2) 4.27 (2.57-7.11) 4.17 (2.50-6.96)
Tumor size
<2 cm 526 (54.9) 42 (29.8) 1.00 1.00
≥2 cm 431 (44.9) 99 (70.2) 2.57 (1.74-3.79) 2.51 (1.70-3.72)
Tx 2 (0.2)
Lymph node status
Negative 577 (58.9) 60 (42.6) 1.00 1.00
Positive 390 (39.8) 78 (55.3) 1.47 (1.03-2.11) 1.46 (1.02-2.09)
Nx 13 (1.3) 3 (2.1)
Hormone status
ER + and/or PR+ 698 (72.6) 74 (53.6) 1.00 1.00
ER–/PR– 264 (27.4) 64 (46.4) 2.06 (1.41-3.01) 2.06 (1.40-3.02)
Nuclear grade
I-II 525 (55.2) 57 (41.0) 1.00 1.00
III 426 (44.8) 82 (59.0) 1.15 (0.78-1.69) 1.12 (0.75-1.65)
Abbreviation: AMC, Asan Medical Center; ER, estrogen receptor; PR, progesterone receptor; SNU, Seoul National University.
Data are presented as frequency (percentage), except for age and BMI in continuous variable, which are expressed as mean (SD).
a Adjusted for age, TNM stage and hormone status and nuclear grade.
b Adjusted for age, education, recruited site, TNM stage, hormone status and nuclear grade.
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Table 2 Association between one-carbon metabolism related nutrients intake and disease progression in breast cancer
patients
All (N= 980) Events (N= 141) Model 1a Model 2b
Vitamin B2 intake, mg
Continuous (mean(SD)) 1.0 (0.4) 1.0 (0.4) 1.21 (0.67-2.18) 1.29 (0.71-2.33)
1st quartile (0.1-0.6) 192 (19.6) 29 (20.6) 1.00 1.00
2nd quartile (0.7-0.8) 226 (23.1) 26 (18.4) 0.94 (0.54-1.61) 0.99 (0.58-1.73)
3rd quartile (0.9-1.1) 295 (30.1) 44 (31.2) 1.20 (0.71-2.02) 1.28 (0.75-2.18)
4th quartile (1.2-3.4) 267 (27.2) 42 (29.8) 1.40 (0.76-2.61) 1.58 (0.84-2.98)
Ptrend 0.21 0.12
Vitamin B6 intake, mg
Continuous (mean(SD)) 1.5 (0.5) 1.5 (0.6) 1.41 (0.90-2.20) 1.38 (0.88-2.17)
1st quartile (0.1-1.0) 174 (17.8) 26 (18.4) 1.00 1.00
2nd quartile (1.1-1.3) 262 (26.7) 39 (27.7) 1.27 (0.75-2.16) 1.28 (0.75-2.18)
3rd quartile (1.4-1.7) 238 (24.3) 27 (19.2) 0.97 (0.72-1.80) 0.98 (0.53-1.83)
4th quartile (1.8-4.8) 306 (31.2) 49 (34.8) 1.61 (0.82-3.16) 1.65 (0.84-3.24)
Ptrend 0.29 0.27
Folate intake, mg
Continuous (mean(SD)) 213.8 (99.3) 212.9 (98.3) 1.00 (0.99-1.00) 1.00 (0.99-1.00)
1st quartile (9–147) 240 (24.5) 37 (26.2) 1.00 1.00
2nd quartile (148–199) 248 (25.3) 32 (22.7) 0.82 (0.51-1.33) 0.82 (0.51-1.34)
3rd quartile (200–256) 247 (25.2) 33 (23.4) 0.96 (0.58-1.60) 0.97 (0.58-1.63)
4th quartile (257–970) 245 (25.0) 39 (27.7) 1.18 (0.68-2.03) 1.20 (0.69-2.07)
Ptrend 0.50 0.46
Combined score
Low (0) 302 (30.8) 44 (31.2) 1.00 1.00
Medium (1–2) 289 (29.5) 35 (24.8) 0.92 (0.58-1.47) 0.93 (0.58-1.50)
High (3) 389 (39.7) 62 (44.0) 1.40 (0.84-2.33) 1.46 (0.87-2.43)
Ptrend 0.20 0.15
Data are presented as frequency (percentage), except for continuous variable, which are expressed as mean (SD).
a Adjusted for age, TNM stage, hormone status, nuclear grade and total calorie.
b Adjusted for age, education, recruited site, TNM stage, hormone status, nuclear grade and total calorie.
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1.86; 95% CI, 0.97-3.56).
Furthermore, we evaluated the association between the
combined scores of one-carbon metabolism related nutri-
ents intake and disease progression in breast cancer
patients stratified by hormone status (Table 4). The posi-
tive association between ER/PR status was profound when
the nutrient intakes were categorized by combined score
(Pinteraction = 0.018). In ER–/PR– cancers, the high com-
bined score (range, 3) group was associated with a signifi-
cantly poor DFS compared to those belonging to the low
score (range, 0) group (HR=3.84; 95% CI, 1.70-8.71).
Discussion
There was no association between one-carbon metabol-
ism related nutrients and disease free survival of breast
cancer overall, while some effects were observed whenstratifying by breast cancer subtypes. To the best of our
knowledge, this study is the first to systematically inves-
tigate the association between the combined effects of
prediagnostic intake of nutrients related to the one-
carbon metabolism pathway and the clinicopathological
characteristics of breast cancer.
In our study, the range for the intake of vitamin B2, B6
and folate were 0.1-3.4 mg, 0.1-4.8 mg and 9–970 mg,
respectively. These levels of vitamin B6 and folate were
less than the tolerable upper intake level of Dietary
Reference Intakes for Koreans (KDRIs). The tolerable
upper intake of vitamin B2 level was not determinable
by the KDRIs. In the KDRIs, the tolerable upper intake
level of vitamin B6 and folate were 100 mg and 1000 mg.
The levels of dietary intake of vitamin B2, B6, and folate
in breast cancer patients were hardly reported. Even
though there were many previous studies on the
Table 3 Association between median of one-carbon metabolism related nutrients and disease progression in breast
cancer patients stratified by clinicopathological characteristics
Below median Above median
No. of total No. of events No. of total No. of events HR (95%CI)a
TNM stage
Vitamin B2, mg I-II 350 39 466 58 1.40 (0.85-2.30)
III 68 16 96 28 1.13 (0.52-2.43)
Vitamin B6, mg I-II 362 46 454 51 1.02 (0.61-1.73)
III 74 19 90 25 1.05 (0.49-2.27)
Folate, mg I-II 397 48 419 49 1.10 (0.69-1.75)
III 91 21 73 23 1.52 (0.77-3.01)
Lymph-node status
Vitamin B2, mg Negative 242 25 335 35 1.28 (0.67-2.42)
Positive 172 29 218 49 1.40 (0.81-2.44)
Vitamin B6, mg Negative 251 28 326 32 1.22 (0.63-2.34)
Positive 181 36 209 42 0.88 (0.49-1.56)
Folate, mg Negative 284 30 293 30 1.23 (0.68-2.24)
Positive 199 38 191 40 1.12 (0.67-1.87)
Hormone status
Vitamin B2, mg ER+ and/or PR+ 300 34 398 40 0.91 (0.52-1.59)
ER–/PR– 111 21 153 43 2.28 (1.20-4.35)
Vitamin B6, mg ER+ and/or PR+ 305 39 393 35 0.57 (0.32-1.03)
ER–/PR– 125 26 139 38 1.86 (0.97-3.56)
Folate, mg ER+ and/or PR+ 333 39 365 35 0.82 (0.49-1.40)
ER–/PR– 148 30 116 34 1.84 (1.02-3.32)
Nuclear grade
Vitamin B2, mg I-II 223 23 302 34 1.22 (0.64-2.34)
III 185 32 241 50 1.43 (0.82-2.49)
Vitamin B6, mg I-II 226 29 299 28 0.56 (0.28-1.11)
III 200 36 226 46 1.28 (0.73-2.24)
Folate, mg I-II 250 31 275 26 0.69 (0.38-1.27)
III 224 38 202 44 1.59 (0.95-2.66)
Abbreviation: ER, estrogen receptor; PR, progesterone receptor.
a Adjusted for age, education, recruited site, TNM stage, hormone status, nuclear grade and total calorie.
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cancer risk, they reported the tertiles or quartile levels in
both the cases and the controls. Thus, it is hard to com-
pare the nutrients intake level of patients’ with other
studies that used different designs.
In observational studies, the results for the relationship
between micronutrient intakes and all-cause mortality
were inconsistent among breast cancer patients [21]. Only
one study investigated one-carbon metabolism related
nutrients intake and all-cause of mortality in women with
breast cancer, and showed null results for vitamin B2, B6
and folate [17]. Few studies have investigated the associ-
ation between folate intake and breast cancer survival.
McEligot et al. studied 516 postmenopausal womendiagnosed with breast cancer for 6.6 years (median fol-
low-up) and showed that women in the highest tertile for
dietary folate intake had an HR of 0.34 (95% CI, 0.18-
0.67) regarding all-cause mortality [22]. In addition, in the
Swedish mammography cohort, dietary folate intake was
inversely associated with overall mortality (HR= 0.79; 95%
CI, 0.66-0.96) [16]. However, in the Iowa Women’s Health
Study, Sellers et al. reported that among 177 breast cancer
patients, folate intake had no association with breast can-
cer prognosis [23]. Moreover, in the Nurses’ Health Study,
Holmes et al. provided additional support for no associ-
ation of breast cancer prognosis with vitamin B2, B6 and
folate [18]. In addition, Rossi et al. measured the folate
levels in plasma from 1024 breast cancer patients in
Table 4 Association between combined score of one-carbon metabolism related nutrients intake and disease
progression in breast cancer patients stratified by selected characteristics
Combined score No. of total No. of events HR (95%CI) a
Hormone statusb
ER + and/or PR+ Low (0) 211 29 1.00
Medium (1–2) 202 16 0.54 (0.29-1.02)
High (3) 285 29 0.72 (0.37-1.43)
Ptrend 0.29
ER–/PR– Low (0) 87 15 1.00
Medium (1–2) 82 19 2.02 (0.96-4.27)
High (3) 95 30 3.84 (1.70-8.71)
Ptrend 0.001
Abbreviation: ER, estrogen receptor; PR, progesterone receptor.
a Adjusted for age, education, recruited site, TNM stage, hormone status, nuclear grade and total calorie.
b P for interaction = 0.018.
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cantly associated with breast cancer survival [24]. No
other prior studies have reported the relationship between
one-carbon metabolism related factors and their com-
bined intake effects on the prognosis of breast cancer.
The lack of consensus in the results of previous studies
could be explained by the variation in study methodolo-
gies, micronutrient source, and total micronutrient level.
Thus, it is difficult to determine how the micronutrient
intake distribution reported in one study compares to
other studies [25].
We observed that the combined intake effects of vita-
min B2, B6, and folate were associated with breast cancer
progression in patients depending on their ER/PR status.
No previous studies examining the combined intake
effects of one-carbon metabolism related nutrients intake
and hormone specific breast cancer have been identified.
In the Swedish Mammography Cohort (SMC), only folate
intake, which is one of the one-carbon metabolism
related nutrients studies, was assessed for association
with breast cancer progression [20]. Although Harris
et al. have reported that dietary folate intake has shown
protective effects on breast cancer-specific mortality in
ER-negative tumors, our results do not support this ef-
fect. It is difficult directly compare our study’s results to
theirs since the distribution of the hormone receptors in
the study subjects was different (ER-negative breast can-
cer, less than 20% in SMC; 39.2% in the present study).
For breast cancer risk, few studies have evaluated the re-
lationship between hormone status and folate intake. A
higher folate intake was associated with a lower risk of
ER-negative breast cancer in the Nurses’ Health Study
[26], and in the VITamins And Lifestyle (VITAL) cohort
[27]. In SMC, a high folate intake was related to a
decreased risk of ER+/PR– breast cancer [28]. Otherwise,
few cohort studies have reported largely null results, with
no findings for associations between folate intake andER+, ER–, PR + or PR– breast cancers [26,27,29,30].
From various laboratory studies, their results were incon-
sistent with our study, which examined whether DNA
methylation of the ER CpG island may play a role in sup-
pressing ER gene expression in ER-negative breast cancer
cells [31,32]. A greater supply of methyl through a high
intake of one-carbon metabolism related nutrients may
induce the suppression of gene expression in patients
with ER–/PR– breast cancers. In addition, a high intake
of one-carbon metabolism related nutrients may have a
stronger effect on ER–/PR– breast cancer progression
than the other types of breast cancers since ER–/PR–
breast cancers are less responsive to hormone therapies.
Further studies are needed to elucidate the possible asso-
ciation between one-carbon metabolism related nutrients
and the hormone receptors in breast cancer patients.
The results of our study were contrary to the hypothesis
based on previous studies that a higher intake of B vita-
mins would have a protective effect on breast cancer sur-
vival in population based studies. One prospective cohort
study suggested the association of major energy sources
with breast cancer survival may be U-shaped rather than
linear [33]. As far as this idea, the association has not yet
been proven; however, a midrange intake of vitamins is
associated with the most favorable outcomes, and
extremes are associated with less favorable outcomes.
This study has some limitations. First, there were likely
errors in our estimate of dietary habits. Patients were
asked about their dietary intake for the year preceding
the diagnosis using the FFQ. Due to this, measurement
errors likely occurred because of poor recall despite the
validity and reproducibility evidence of the question-
naire. The FFQ correlations were lower than that
reported in western countries which were between 0.5-
0.7 [34]. In Asia, the median of the correlation coeffi-
cients for the FFQ has ranged from 0.3-0.5 in Japan
[35,36] and Korea [37,38], and a lower FFQ correlation
Lee et al. Nutrition Journal 2012, 11:59 Page 8 of 9
http://www.nutritionj.com/content/11/1/59may have been caused by the dining etiquette and cul-
tural foods of Korea [20]. Though the correlation coeffi-
cients were low, to date, FFQ is the only method in
which long-term usual dietary intake of an individual
can be easily obtained with a single measurement [39].
Second, intake of supplements was not available for the
calculations. However, the intake of supplements use
can improve the dietary quality for certain micronutri-
ents [25]. Lastly, we could not evaluate the association
between one-carbon metabolism related nutrients and
breast cancer specific mortality because the data for the
cause of death were not available. Thus, the results must
be interpreted cautiously and need to be confirmed by a
study that investigates the association of one-carbon me-
tabolism related nutrients with breast cancer specific
survival.
Nevertheless, our study has strengths. It is the first
study to evaluate the association between the combined
intake effects of vitamin B2, B6 and folate and hormone
specific breast cancer survival.
Conclusion
In summary, one-carbon metabolism related nutrients
are associated with disease free survival depending on
the ER/PR status among breast cancer patients. How-
ever, because of the small population in these subgroup
analyses, these results should be interpreted with cau-
tion. Future studies examining the pathways of one-
carbon metabolism related nutrients in certain breast
cancer types must account for the direct or indirect roles
of these nutrients.
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